|
fibrinolysis
|
GO:0042730 |
3 |
0.506
|
|
|
plasma lipoprotein particle remodeling
|
GO:0034369 |
6 |
0.347
|
|
|
sterol metabolic process
|
GO:0016125 |
58 |
0.322
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.302
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.286
|
|
|
negative regulation of protein processing
|
GO:0010955 |
79 |
0.275
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.248
|
|
|
lipid homeostasis
|
GO:0055088 |
63 |
0.228
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.221
|
|
|
organic anion transport
|
GO:0015711 |
137 |
0.211
|
|
|
muscle cell differentiation
|
GO:0042692 |
261 |
0.184
|
|
|
protein processing
|
GO:0016485 |
163 |
0.177
|
|
|
neutral lipid metabolic process
|
GO:0006638 |
57 |
0.169
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.160
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.159
|
|
|
regulation of protein processing
|
GO:0070613 |
96 |
0.156
|
|
|
cholesterol metabolic process
|
GO:0008203 |
56 |
0.146
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.142
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.139
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.139
|
|
|
digestion
|
GO:0007586 |
40 |
0.136
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.135
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.129
|
|
|
negative regulation of fibrinolysis
|
GO:0051918 |
1 |
0.126
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.121
|
|
|
folic acid containing compound metabolic process
|
GO:0006760 |
3 |
0.121
|
|
|
negative regulation of peptidase activity
|
GO:0010466 |
46 |
0.116
|
|
|
regulation of protein maturation
|
GO:1903317 |
96 |
0.114
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.106
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.103
|
|
|
lipoprotein metabolic process
|
GO:0042157 |
43 |
0.103
|
|
|
cholesterol homeostasis
|
GO:0042632 |
44 |
0.102
|
|
|
anion transport
|
GO:0006820 |
177 |
0.101
|
|
|
organic acid transport
|
GO:0015849 |
101 |
0.100
|
|
|
sterol homeostasis
|
GO:0055092 |
45 |
0.097
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.095
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.092
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.089
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.089
|
|
|
acylglycerol metabolic process
|
GO:0006639 |
55 |
0.085
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.084
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.083
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.083
|
|
|
sterol esterification
|
GO:0034434 |
3 |
0.082
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.081
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.081
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.081
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.080
|
|
|
glycerolipid metabolic process
|
GO:0046486 |
122 |
0.080
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.077
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.076
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.075
|
|
|
renal system development
|
GO:0072001 |
225 |
0.075
|
|
|
triglyceride metabolic process
|
GO:0006641 |
51 |
0.074
|
|
|
high density lipoprotein particle assembly
|
GO:0034380 |
3 |
0.074
|
|
|
response to acid chemical
|
GO:0001101 |
111 |
0.073
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.073
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.071
|
|
|
aspartate family amino acid metabolic process
|
GO:0009066 |
10 |
0.070
|
|
|
regulation of intestinal cholesterol absorption
|
GO:0030300 |
4 |
0.067
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.067
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.064
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.064
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.062
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.061
|
|
|
striated muscle cell development
|
GO:0055002 |
125 |
0.060
|
|
|
negative regulation of coagulation
|
GO:0050819 |
11 |
0.058
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.058
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.058
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.058
|
|
|
triglyceride rich lipoprotein particle remodeling
|
GO:0034370 |
2 |
0.057
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.057
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.056
|
|
|
triglyceride homeostasis
|
GO:0070328 |
15 |
0.056
|
|
|
kidney development
|
GO:0001822 |
213 |
0.055
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.053
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.052
|
|
|
regulation of plasma lipoprotein particle levels
|
GO:0097006 |
23 |
0.052
|
|
|
very low density lipoprotein particle remodeling
|
GO:0034372 |
1 |
0.052
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.052
|
|
|
myosin filament organization
|
GO:0031033 |
3 |
0.051
|
|
|
gland development
|
GO:0048732 |
330 |
0.051
|
|
|
trophoblast giant cell differentiation
|
GO:0060707 |
15 |
0.050
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.050
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.049
|
|
|
nucleoside monophosphate metabolic process
|
GO:0009123 |
85 |
0.049
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.048
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.048
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.047
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.046
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.046
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.046
|
|
|
wound healing
|
GO:0042060 |
157 |
0.045
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.045
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.045
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.045
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.045
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.045
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.045
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.044
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.044
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.044
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.043
|
|
|
cell adhesion
|
GO:0007155 |
329 |
0.043
|
|
|
response to oxygen levels
|
GO:0070482 |
62 |
0.043
|
|
|
sterol transport
|
GO:0015918 |
38 |
0.043
|
|
|
regulation of plasminogen activation
|
GO:0010755 |
4 |
0.042
|
|
|
cholesterol import
|
GO:0070508 |
2 |
0.042
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.042
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.042
|
|
|
cholesterol transport
|
GO:0030301 |
38 |
0.042
|
|
|
visual perception
|
GO:0007601 |
52 |
0.042
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.040
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.040
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.039
|
|
|
retina morphogenesis in camera type eye
|
GO:0060042 |
45 |
0.039
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.039
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.038
|
|
|
regulation of peptide transport
|
GO:0090087 |
91 |
0.038
|
|
|
cation transport
|
GO:0006812 |
399 |
0.038
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.038
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.038
|
|
|
muscle cell development
|
GO:0055001 |
133 |
0.037
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.037
|
|
|
amide transport
|
GO:0042886 |
138 |
0.037
|
|
|
liver development
|
GO:0001889 |
66 |
0.036
|
|
|
myosin filament assembly
|
GO:0031034 |
2 |
0.036
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.036
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.036
|
|
|
response to nutrient levels
|
GO:0031667 |
109 |
0.036
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
79 |
0.035
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.035
|
|
|
regulation of microvillus assembly
|
GO:0032534 |
3 |
0.035
|
|
|
regulation of fibrinolysis
|
GO:0051917 |
1 |
0.034
|
|
|
phospholipid homeostasis
|
GO:0055091 |
6 |
0.034
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.034
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.033
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.033
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.033
|
|
|
negative regulation of hemostasis
|
GO:1900047 |
11 |
0.033
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.033
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.033
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.032
|
|
|
cholesterol esterification
|
GO:0034435 |
3 |
0.032
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.032
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.032
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.032
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.032
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.032
|
|
|
protein oxidation
|
GO:0018158 |
2 |
0.032
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.032
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.032
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.032
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.032
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.032
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.032
|
|
|
protein oligomerization
|
GO:0051259 |
67 |
0.031
|
|
|
carboxylic acid transport
|
GO:0046942 |
100 |
0.031
|
|
|
multi multicellular organism process
|
GO:0044706 |
109 |
0.031
|
|
|
cofactor metabolic process
|
GO:0051186 |
80 |
0.031
|
|
|
positive regulation of response to wounding
|
GO:1903036 |
66 |
0.031
|
|
|
negative regulation of blood coagulation
|
GO:0030195 |
11 |
0.031
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.030
|
|
|
positive regulation of plasminogen activation
|
GO:0010756 |
2 |
0.030
|
|
|
sterol transmembrane transport
|
GO:0035382 |
2 |
0.030
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.030
|
|
|
limb development
|
GO:0060173 |
166 |
0.030
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.029
|
|
|
regulation of defense response
|
GO:0031347 |
233 |
0.029
|
|
|
long chain fatty acid import
|
GO:0044539 |
2 |
0.029
|
|
|
innate immune response in mucosa
|
GO:0002227 |
3 |
0.029
|
|
|
regulation of cell adhesion
|
GO:0030155 |
154 |
0.029
|
|
|
nephron epithelium morphogenesis
|
GO:0072088 |
68 |
0.029
|
|
|
regulation of vasculature development
|
GO:1901342 |
88 |
0.029
|
|
|
lipoprotein catabolic process
|
GO:0042159 |
7 |
0.029
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.029
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.029
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.028
|
|
|
cell growth
|
GO:0016049 |
130 |
0.028
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.028
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.028
|
|
|
hepatocyte growth factor receptor signaling pathway
|
GO:0048012 |
3 |
0.028
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.028
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.028
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.028
|
|
|
ossification
|
GO:0001503 |
216 |
0.028
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.028
|
|
|
chromatin modification
|
GO:0016568 |
187 |
0.028
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.028
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.028
|
|
|
peptide transport
|
GO:0015833 |
133 |
0.028
|
|
|
small molecule catabolic process
|
GO:0044282 |
71 |
0.028
|
|
|
mitral valve morphogenesis
|
GO:0003183 |
4 |
0.028
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.027
|
|
|
tendon cell differentiation
|
GO:0035990 |
4 |
0.027
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.027
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.027
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.027
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.027
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.027
|
|
|
chromatin organization
|
GO:0006325 |
206 |
0.027
|
|
|
regulation of phosphatidylinositol 3 kinase signaling
|
GO:0014066 |
30 |
0.027
|
|
|
negative regulation of endothelial cell migration
|
GO:0010596 |
4 |
0.027
|
|
|
cellular response to acid chemical
|
GO:0071229 |
68 |
0.027
|
|
|
regulation of inflammatory response
|
GO:0050727 |
147 |
0.027
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.026
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.026
|
|
|
striated muscle myosin thick filament assembly
|
GO:0071688 |
1 |
0.026
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.026
|
|
|
one carbon metabolic process
|
GO:0006730 |
1 |
0.026
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.026
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.026
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.026
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.026
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.026
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.026
|
|
|
coagulation
|
GO:0050817 |
78 |
0.026
|
|
|
steroid esterification
|
GO:0034433 |
3 |
0.025
|
|
|
intestinal absorption
|
GO:0050892 |
13 |
0.025
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.025
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.025
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.025
|
|
|
very long chain fatty acid catabolic process
|
GO:0042760 |
2 |
0.025
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
151 |
0.025
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.025
|
|
|
retinoic acid metabolic process
|
GO:0042573 |
12 |
0.025
|
|
|
regulation of sterol transport
|
GO:0032371 |
17 |
0.025
|
|
|
calcium ion homeostasis
|
GO:0055074 |
127 |
0.025
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.025
|
|
|
activation of membrane attack complex
|
GO:0001905 |
4 |
0.024
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.024
|
|
|
lung development
|
GO:0030324 |
164 |
0.024
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.024
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.024
|
|
|
protein lipid complex subunit organization
|
GO:0071825 |
12 |
0.024
|
|
|
lipoprotein biosynthetic process
|
GO:0042158 |
33 |
0.024
|
|
|
carbohydrate homeostasis
|
GO:0033500 |
128 |
0.024
|
|
|
negative regulation of cell development
|
GO:0010721 |
169 |
0.024
|
|
|
cell differentiation involved in embryonic placenta development
|
GO:0060706 |
26 |
0.024
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.024
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.023
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.023
|
|
|
cellular protein complex assembly
|
GO:0043623 |
116 |
0.023
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.023
|
|
|
response to hypoxia
|
GO:0001666 |
58 |
0.023
|
|
|
maintenance of location
|
GO:0051235 |
89 |
0.023
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.023
|
|
|
sensory perception of light stimulus
|
GO:0050953 |
54 |
0.023
|
|
|
muscle tissue development
|
GO:0060537 |
308 |
0.023
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.023
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.023
|
|
|
regulation of tube size
|
GO:0035150 |
57 |
0.023
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.023
|
|
|
negative regulation of cell adhesion
|
GO:0007162 |
45 |
0.023
|
|
|
acylglycerol homeostasis
|
GO:0055090 |
16 |
0.023
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.022
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.022
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.022
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.022
|
|
|
renal tubule development
|
GO:0061326 |
87 |
0.022
|
|
|
cellular biogenic amine metabolic process
|
GO:0006576 |
28 |
0.022
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.022
|
|
|
epithelial cell maturation involved in prostate gland development
|
GO:0060743 |
4 |
0.022
|
|
|
cellular modified amino acid metabolic process
|
GO:0006575 |
63 |
0.022
|
|
|
glucose homeostasis
|
GO:0042593 |
128 |
0.022
|
|
|
nucleoside monophosphate catabolic process
|
GO:0009125 |
59 |
0.021
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.021
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.021
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.021
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.021
|
|
|
c4 dicarboxylate transport
|
GO:0015740 |
3 |
0.021
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.021
|
|
|
amino acid transport
|
GO:0006865 |
61 |
0.021
|
|
|
atp metabolic process
|
GO:0046034 |
75 |
0.021
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.021
|
|
|
extracellular matrix organization
|
GO:0030198 |
147 |
0.021
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.021
|
|
|
neural retina development
|
GO:0003407 |
41 |
0.021
|
|
|
bmp signaling pathway
|
GO:0030509 |
93 |
0.021
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.021
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.021
|
|
|
muscle contraction
|
GO:0006936 |
101 |
0.021
|
|
|
purine ribonucleoside monophosphate metabolic process
|
GO:0009167 |
80 |
0.021
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.021
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.020
|
|
|
response to peptide
|
GO:1901652 |
136 |
0.020
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.020
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.020
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.020
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.020
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.020
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.020
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.020
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.020
|
|
|
regulation of blood coagulation
|
GO:0030193 |
28 |
0.020
|
|
|
organ growth
|
GO:0035265 |
117 |
0.020
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.020
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.020
|
|
|
regulation of peptide secretion
|
GO:0002791 |
77 |
0.020
|
|
|
innate immune response
|
GO:0045087 |
157 |
0.020
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.020
|
|
|
astrocyte fate commitment
|
GO:0060018 |
4 |
0.020
|
|
|
sodium ion transport
|
GO:0006814 |
73 |
0.020
|
|
|
alpha amino acid biosynthetic process
|
GO:1901607 |
15 |
0.020
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.020
|
|
|
connective tissue replacement involved in inflammatory response wound healing
|
GO:0002248 |
3 |
0.020
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.019
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.019
|
|
|
anion transmembrane transport
|
GO:0098656 |
71 |
0.019
|
|
|
ribonucleoside monophosphate metabolic process
|
GO:0009161 |
80 |
0.019
|
|
|
divalent inorganic cation homeostasis
|
GO:0072507 |
138 |
0.019
|
|
|
amino acid transmembrane transport
|
GO:0003333 |
37 |
0.019
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.019
|
|
|
iron ion homeostasis
|
GO:0055072 |
36 |
0.019
|
|
|
regulation of mast cell differentiation
|
GO:0060375 |
3 |
0.019
|
|
|
skeletal muscle cell differentiation
|
GO:0035914 |
66 |
0.019
|
|
|
multicellular organismal macromolecule metabolic process
|
GO:0044259 |
19 |
0.019
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.019
|
|
|
blood vessel endothelial cell migration
|
GO:0043534 |
23 |
0.019
|
|
|
regulation of hemostasis
|
GO:1900046 |
28 |
0.019
|
|
|
regulation of wound healing
|
GO:0061041 |
40 |
0.019
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.019
|
|
|
regulation of cell substrate adhesion
|
GO:0010810 |
73 |
0.019
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.019
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.019
|
|
|
cellular response to organic cyclic compound
|
GO:0071407 |
87 |
0.019
|
|
|
purine nucleoside monophosphate catabolic process
|
GO:0009128 |
58 |
0.019
|
|
|
protein lipid complex remodeling
|
GO:0034368 |
6 |
0.019
|
|
|
low density lipoprotein particle remodeling
|
GO:0034374 |
2 |
0.019
|
|
|
paraxial mesodermal cell differentiation
|
GO:0048342 |
2 |
0.018
|
|
|
collagen metabolic process
|
GO:0032963 |
17 |
0.018
|
|
|
coenzyme metabolic process
|
GO:0006732 |
52 |
0.018
|
|
|
positive regulation of transcription from rna polymerase ii promoter involved in norepinephrine biosynthetic process
|
GO:2000763 |
1 |
0.018
|
|
|
inositol lipid mediated signaling
|
GO:0048017 |
41 |
0.018
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.018
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.018
|
|
|
gonad development
|
GO:0008406 |
141 |
0.018
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.018
|
|
|
pallium development
|
GO:0021543 |
120 |
0.018
|
|
|
cholesterol efflux
|
GO:0033344 |
24 |
0.018
|
|
|
regulation of cytokine secretion involved in immune response
|
GO:0002739 |
4 |
0.018
|
|
|
alcohol metabolic process
|
GO:0006066 |
116 |
0.018
|
|
|
transition metal ion homeostasis
|
GO:0055076 |
54 |
0.018
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.018
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.018
|
|
|
purine nucleoside monophosphate metabolic process
|
GO:0009126 |
81 |
0.018
|
|
|
positive regulation of cholesterol esterification
|
GO:0010873 |
1 |
0.018
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.018
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.018
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.018
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.018
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.018
|
|
|
positive regulation of activation of membrane attack complex
|
GO:0001970 |
2 |
0.018
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.018
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.018
|
|
|
regulation of microvillus organization
|
GO:0032530 |
3 |
0.018
|
|
|
endocardial cushion to mesenchymal transition involved in heart valve formation
|
GO:0003199 |
4 |
0.018
|
|
|
monocarboxylic acid transport
|
GO:0015718 |
44 |
0.018
|
|
|
salivary gland morphogenesis
|
GO:0007435 |
33 |
0.018
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.018
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.017
|
|
|
regulation of embryonic development
|
GO:0045995 |
71 |
0.017
|
|
|
mesoderm formation
|
GO:0001707 |
62 |
0.017
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.017
|
|
|
ear development
|
GO:0043583 |
200 |
0.017
|
|
|
anion homeostasis
|
GO:0055081 |
16 |
0.017
|
|
|
myoblast differentiation
|
GO:0045445 |
52 |
0.017
|
|
|
positive regulation of peptide hormone secretion
|
GO:0090277 |
31 |
0.017
|
|
|
zymogen activation
|
GO:0031638 |
41 |
0.017
|
|
|
secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development
|
GO:0060528 |
4 |
0.017
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.017
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.017
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.017
|
|
|
positive regulation of cholesterol homeostasis
|
GO:2000189 |
2 |
0.017
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.017
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.017
|
|
|
regionalization
|
GO:0003002 |
337 |
0.017
|
|
|
hair cell differentiation
|
GO:0035315 |
40 |
0.017
|
|
|
cardiocyte differentiation
|
GO:0035051 |
87 |
0.017
|
|
|
macromolecule glycosylation
|
GO:0043413 |
55 |
0.017
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.017
|
|
|
negative regulation of gliogenesis
|
GO:0014014 |
23 |
0.017
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.017
|
|
|
diterpenoid metabolic process
|
GO:0016101 |
24 |
0.017
|
|
|
extrinsic apoptotic signaling pathway via death domain receptors
|
GO:0008625 |
34 |
0.017
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.017
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.017
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.017
|
|
|
regulation of protein stability
|
GO:0031647 |
52 |
0.017
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.017
|
|
|
regulation of circadian rhythm
|
GO:0042752 |
58 |
0.017
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.017
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.016
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.016
|
|
|
bone morphogenesis
|
GO:0060349 |
78 |
0.016
|
|
|
regulation of toll signaling pathway
|
GO:0008592 |
1 |
0.016
|
|
|
endochondral bone morphogenesis
|
GO:0060350 |
50 |
0.016
|
|
|
negative regulation of serine type endopeptidase activity
|
GO:1900004 |
2 |
0.016
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.016
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.016
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.016
|
|
|
regulation of phosphatidylcholine biosynthetic process
|
GO:2001245 |
2 |
0.016
|
|
|
regulation of fatty acid biosynthetic process
|
GO:0042304 |
12 |
0.016
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.016
|
|
|
response to temperature stimulus
|
GO:0009266 |
55 |
0.016
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.016
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.016
|
|
|
limb morphogenesis
|
GO:0035108 |
149 |
0.016
|
|
|
chondrocyte development
|
GO:0002063 |
24 |
0.016
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.016
|
|
|
pteridine containing compound metabolic process
|
GO:0042558 |
5 |
0.016
|
|
|
dicarboxylic acid transport
|
GO:0006835 |
29 |
0.016
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.016
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
56 |
0.016
|
|
|
regulation of muscle system process
|
GO:0090257 |
80 |
0.016
|
|
|
artery development
|
GO:0060840 |
53 |
0.016
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.016
|
|
|
formation of primary germ layer
|
GO:0001704 |
77 |
0.016
|
|
|
placenta development
|
GO:0001890 |
140 |
0.016
|
|
|
positive regulation of translational initiation
|
GO:0045948 |
4 |
0.015
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.015
|
|
|
cholesterol biosynthetic process
|
GO:0006695 |
15 |
0.015
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.015
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.015
|
|
|
positive regulation of protein kinase c activity
|
GO:1900020 |
1 |
0.015
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.015
|
|
|
positive regulation of auditory receptor cell differentiation
|
GO:0045609 |
1 |
0.015
|
|
|
regulation of peptide hormone secretion
|
GO:0090276 |
75 |
0.015
|
|
|
negative regulation of cytokine production
|
GO:0001818 |
84 |
0.015
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.015
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.015
|
|
|
establishment of vesicle localization
|
GO:0051650 |
81 |
0.015
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.015
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.015
|
|
|
collagen fibril organization
|
GO:0030199 |
32 |
0.015
|
|
|
heart process
|
GO:0003015 |
94 |
0.015
|
|
|
platelet derived growth factor receptor signaling pathway
|
GO:0048008 |
32 |
0.015
|
|
|
astrocyte differentiation
|
GO:0048708 |
43 |
0.015
|
|
|
regulation of morphogenesis of a branching structure
|
GO:0060688 |
53 |
0.015
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.015
|
|
|
nephron tubule development
|
GO:0072080 |
84 |
0.015
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.015
|
|
|
positive regulation of fatty acid biosynthetic process
|
GO:0045723 |
3 |
0.015
|
|
|
peptidyl lysine modification
|
GO:0018205 |
77 |
0.015
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.015
|
|
|
circadian rhythm
|
GO:0007623 |
114 |
0.015
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
62 |
0.015
|
|
|
atp catabolic process
|
GO:0006200 |
55 |
0.015
|
|
|
norepinephrine transport
|
GO:0015874 |
2 |
0.015
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.015
|
|
|
regulation of angiogenesis
|
GO:0045765 |
81 |
0.015
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
95 |
0.014
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.014
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.014
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
131 |
0.014
|
|
|
regulation of transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0090092 |
112 |
0.014
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.014
|
|
|
vitamin a metabolic process
|
GO:0006776 |
2 |
0.014
|
|
|
regulation of organ morphogenesis
|
GO:2000027 |
144 |
0.014
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.014
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.014
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.014
|
|
|
lymphocyte mediated immunity
|
GO:0002449 |
139 |
0.014
|
|
|
positive regulation of neuron differentiation
|
GO:0045666 |
141 |
0.014
|
|
|
lateral inhibition
|
GO:0046331 |
1 |
0.014
|
|
|
activation of mapk activity
|
GO:0000187 |
59 |
0.014
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.014
|
|
|
cardiac ventricle morphogenesis
|
GO:0003208 |
50 |
0.014
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.014
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.014
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.014
|
|
|
glucose metabolic process
|
GO:0006006 |
92 |
0.014
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.014
|
|
|
positive regulation of fatty acid oxidation
|
GO:0046321 |
4 |
0.014
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.014
|
|
|
protein import
|
GO:0017038 |
101 |
0.014
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.014
|
|
|
regulation of myeloid leukocyte differentiation
|
GO:0002761 |
58 |
0.014
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
123 |
0.014
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.014
|
|
|
cardiac muscle tissue morphogenesis
|
GO:0055008 |
44 |
0.014
|
|
|
regulation of cholesterol esterification
|
GO:0010872 |
2 |
0.014
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.014
|
|
|
smad protein signal transduction
|
GO:0060395 |
21 |
0.014
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.014
|
|